Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a page revision or software update. This change does not modify the study details or other substantive content on the page.
    Difference
    0.0%
    Check dated 2026-08-29T18:32:55.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a new publication citation about BRAF p.V600E mutation monitoring in cerebrospinal fluid during BRAF/MEK inhibitor therapy for papillary craniopharyngioma to the study's publications section.
    Difference
    0.0%
    Check dated 2026-08-15T11:35:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s backend or content.
    Difference
    0.0%
    Check dated 2026-08-08T09:20:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, reflecting a new revision of the page without changes to study details or core content.
    Difference
    0.0%
    Check dated 2026-07-25T05:25:48.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor version update. This change does not modify the study details or other essential information displayed to users.
    Difference
    0.0%
    Check dated 2026-07-03T22:00:32.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page revision badge updated from v3.6.0 to v3.6.2, indicating a minor update to the page rendering and metadata.
    Difference
    0.0%
    Check dated 2026-06-26T19:48:20.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.